🔗 Visit the ClinicalTrials.gov page for NCT00727233
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Plexiform neurofibromas. | Am J Med Genet | 1999 | 2.97 |
| 2 | Targeting protein kinases in central nervous system disorders. | Nat Rev Drug Discov | 2009 | 1.45 |
| 3 | Phase I trial and pharmacokinetic study of the farnesyltransferase inhibitor tipifarnib in children with refractory solid tumors or neurofibromatosis type I and plexiform neurofibromas. | J Clin Oncol | 2006 | 1.40 |
| 4 | Endocrine tumours in neurofibromatosis type 1, tuberous sclerosis and related syndromes. | Best Pract Res Clin Endocrinol Metab | 2010 | 1.35 |
| 5 | Advances in the treatment of neurofibromatosis-associated tumours. | Nat Rev Clin Oncol | 2013 | 1.26 |
| 6 | Neurofibromatosis 1: clinical manifestations and diagnostic criteria. | J Child Neurol | 2002 | 1.24 |
| 7 | Neurofibromatosis 2011: a report of the Children's Tumor Foundation annual meeting. | Acta Neuropathol | 2011 | 0.83 |
| 8 | Advances in paediatric cancer treatment. | Transl Pediatr | 2014 | 0.76 |